ResoTher Pharma management is pleased to announce that Joel Scherer, MD has joined the company´s Scientific Advisory Board. Dr. Scherer brings considerable drug development and cardiology expertise from his former roles as Chief Medical Officer, Managing Director at Chorus (Eli Lilly). Previously, Dr. Scherer served as Head of Cardiovascular at Eli Lilly & Co. Dr. Scherer´s deep expertise with cardiovascular drug development is a major asset to ResoTher Pharma and we are thrilled to welcome him in the capacity of Scientific Advisor.
Joel Scherer, MD joins Scientific Advisory Board
|Published on: Sep 18, 2018||